Structures by: Shankland K.
Total: 138
Cytenamide--butyric acid (1/1)
C16H13NO,C4H8O2
Acta Crystallographica Section E (2008) 64, 7 o1295-o1296
a=5.9351(2)Å b=16.3595(5)Å c=17.6738(4)Å
α=90° β=98.046(2)° γ=90°
Cytenamide trifluoroacetic acid solvate
C16H13NO,C2HF3O2
Acta Crystallographica Section E (2008) 64, 7 o1215-o1216
a=12.1673(11)Å b=6.3235(6)Å c=21.4525(15)Å
α=90° β=101.932(8)° γ=90°
Cytenamide--1,4-dioxane (2/1)
2C16H13NO,C4H8O2
Acta Crystallographica Section E (2008) 64, 7 o1345-o1346
a=24.0888(7)Å b=5.6066(2)Å c=21.1050(6)Å
α=90° β=90.313(3)° γ=90°
Cyheptamide
C16H15NO
Acta Crystallographica Section E (2007) 63, 1 o205-o206
a=5.6035(7)Å b=9.1716(11)Å c=23.579(3)Å
α=90.00° β=96.752(12)° γ=90.00°
(R)-1-phenylethylammonium (R)-2-phenylbutyrate
C8H12N,C10H11O2
Acta Crystallographica Section E (2007) 63, 1 o202-o204
a=11.88215(15)Å b=5.97647(8)Å c=13.07499(15)Å
α=90° β=113.5100(10)° γ=90°
Bendroflumethiazide acetone solvate
C15H14F3N3O4S2,C3H6O
Acta Crystallographica Section C (2007) 63, 11 o659-o663
a=8.192(2)Å b=9.525(2)Å c=14.101(2)Å
α=99.538(17)° β=100.171(17)° γ=100.42(2)°
Bendroflumethiazide N,N-dimethylformamide solvate
C15H14F3N3O4S2,C3H7NO
Acta Crystallographica Section C (2007) 63, 11 o659-o663
a=8.2527(3)Å b=17.8431(7)Å c=14.9012(5)Å
α=90° β=103.752(4)° γ=90°
<i>catena</i>-poly[[[tetraaquamagnesium(II)]-μ-phenylacetato- κ^2^<i>O</i>:<i>O</i>] phenylacetate]
C8H15MgO6,C8H7O2
Acta Crystallographica Section C (2012) 68, 2 m29-m33
a=9.7979(7)Å b=10.0424(8)Å c=36.052(3)Å
α=90.00° β=90.00° γ=90.00°
<i>catena</i>-poly[[[diaqua(phenylacetato- κ^2^<i>O</i>,<i>O</i>)strontium(II)]- μ~3~-phenylacetato-1':1:1''κ^4^<i>O</i>:<i>O</i>,<i>O</i>':<i>O</i>'] monohydrate]
C16H18O6Sr,H2O
Acta Crystallographica Section C (2012) 68, 2 m29-m33
a=29.5111(15)Å b=6.8560(5)Å c=17.7229(11)Å
α=90.00° β=93.453(3)° γ=90.00°
C17H25NO6
C17H25NO6
Journal of the American Chemical Society (2019)
a=6.4204(2)Å b=11.9299(4)Å c=11.1764(4)Å
α=90° β=95.772(3)° γ=90°
C10H9N2,C4HO4
C10H9N2,C4HO4
Journal of the American Chemical Society (2009) 131, 3884-3893
a=3.7551(5)Å b=11.2066(13)Å c=27.322(3)Å
α=90° β=92.947(7)° γ=90°
C10H9N2,C4HO4
C10H9N2,C4HO4
Journal of the American Chemical Society (2009) 131, 3884-3893
a=3.79750(10)Å b=11.1996(3)Å c=27.4424(7)Å
α=90° β=92.236(2)° γ=90°
C10H9N2,C4HO4
C10H9N2,C4HO4
Journal of the American Chemical Society (2009) 131, 3884-3893
a=12.359(8)Å b=11.287(7)Å c=9.061(6)Å
α=90° β=109.139(10)° γ=90°
2(C5H5ClN),Cl4Cu
2(C5H5ClN),Cl4Cu
Journal of the American Chemical Society (2006) 128, 9584-9585
a=7.1853(3)Å b=7.6605(3)Å c=15.4482(6)Å
α=82.336(3)° β=80.555(3)° γ=70.735(3)°
2(C5H5ClN),Cl4Cu
2(C5H5ClN),Cl4Cu
Journal of the American Chemical Society (2006) 128, 9584-9585
a=7.3119(4)Å b=7.7799(4)Å c=15.4970(8)Å
α=81.684(3)° β=79.779(3)° γ=69.368(3)°
Bis(3-chloropyridine)copper(II) chloride
C10H8Cl4CuN2
Journal of the American Chemical Society (2006) 128, 9584-9585
a=3.813149(51)Å b=13.70256(16)Å c=12.11849(19)Å
α=90° β=92.3372(11)° γ=90°
2(C5H5BrN),Cl4Cu
2(C5H5BrN),Cl4Cu
Journal of the American Chemical Society (2006) 128, 9584-9585
a=7.5702(5)Å b=7.8282(6)Å c=15.5620(11)Å
α=82.064(4)° β=78.890(4)° γ=67.093(4)°
2(C5H5BrN),Cl4Cu
2(C5H5BrN),Cl4Cu
Journal of the American Chemical Society (2006) 128, 9584-9585
a=7.407(4)Å b=7.703(4)Å c=15.506(8)Å
α=82.644(10)° β=79.837(10)° γ=68.888(9)°
2(C5H5BrN),Cl4Cu
2(C5H5BrN),Cl4Cu
Journal of the American Chemical Society (2006) 128, 9584-9585
a=7.56821(22)Å b=7.82283(22)Å c=15.55510(44)Å
α=82.1012(15)° β=78.9087(17)° γ=67.0878(15)°
Bis(3-bromopyridine)copper(II) chloride
C10H8Br2Cl2CuN2
Journal of the American Chemical Society (2006) 128, 9584-9585
a=3.88094(28)Å b=13.83710(92)Å c=12.16111(84)Å
α=90° β=91.4741(21)° γ=90°
2(C5H5ClN),Cl4Cu
2(C5H5ClN),Cl4Cu
Journal of the American Chemical Society (2006) 128, 9584-9585
a=7.30931(17)Å b=7.77643(18)Å c=15.49792(37)Å
α=81.6898(14)° β=79.7745(16)° γ=69.3487(15)°
C56H40N8O16
C56H40N8O16
Journal of the American Chemical Society (2009) 131, 11 3884-3893
a=12.4300(27)Å b=11.2743(12)Å c=9.0678(22)Å
α=90.000° β=109.488(14)° γ=90.000°
Remacemide
C17H20N2O
Crystal Growth & Design (2005) 5, 2 427
a=8.9200(10)Å b=16.524(2)Å c=9.8570(10)Å
α=90.00° β=93.836(10)° γ=90.00°
Remacemide nitrate
C17H21N2O1,N1O3
Crystal Growth & Design (2005) 5, 2 427
a=11.724(4)Å b=8.932(4)Å c=15.872(4)Å
α=90.00° β=95.93(2)° γ=90.00°
Remacemide xinafoate
C17H21N2O1,C11H7O3
Crystal Growth & Design (2005) 5, 2 427
a=11.9187(10)Å b=31.801(3)Å c=7.9304(7)Å
α=90.00° β=128.382(2)° γ=90.00°
Remacemide acetate
C17H21N2O1,C2H3O2
Crystal Growth & Design (2005) 5, 2 427
a=15.4018(3)Å b=6.7683(1)Å c=17.3531(3)Å
α=90.0° β=93.13(1)° γ=90.0°
Remacemide napsilate
C17H21N2O1,C10H7SO3,0.4(C2H6O1),0.5(H2O1)
Crystal Growth & Design (2005) 5, 2 427
a=9.7297(4)Å b=14.4323(3)Å c=19.4269(4)Å
α=104.859(2)° β=90.490(2)° γ=95.546(2)°
C15H13ClN2O
C15H13ClN2O
Crystal Growth & Design (2013) 13, 11 5121
a=14.1099(3)Å b=17.4778(3)Å c=5.3403(2)Å
α=90.00° β=90.00° γ=90.00°
C15H13ClN2O
C15H13ClN2O
Crystal Growth & Design (2013) 13, 11 5121
a=7.6241(3)Å b=9.5476(4)Å c=17.8401(7)Å
α=90.00° β=90.00° γ=90.00°
C16H16.6Cl0.4NO2.6
C16H16.6Cl0.4NO2.6
Crystal Growth & Design (2013) 13, 11 5121
a=20.2651(9)Å b=5.8463(3)Å c=23.8489(9)Å
α=90.00° β=95.724(4)° γ=90.00°
C15H15BrN2O2
C15H15BrN2O2
Crystal Growth & Design (2013) 13, 11 5121
a=5.0943(11)Å b=11.110(2)Å c=26.065(5)Å
α=90.00° β=91.646(19)° γ=90.00°
C15H15.5Cl0.5N2O2.5
C15H15.5Cl0.5N2O2.5
Crystal Growth & Design (2013) 13, 11 5121
a=29.4803(17)Å b=4.9462(2)Å c=21.6558(13)Å
α=90.00° β=119.462(8)° γ=90.00°
<i>catena</i>-poly[[[diaqua(phenylacetato-κ^2^<i>O</i>,<i>O</i>)calcium(II)]- μ~3~-phenylacetato-1':1:1''κ^4^<i>O</i>:<i>O</i>,<i>O</i>':<i>O</i>'] monohydrate]
C16H18CaO6,H2O
Acta Crystallographica Section C (2012) 68, 2 m29-m33
a=29.2249(10)Å b=6.6941(3)Å c=17.8109(5)Å
α=90.00° β=92.520(2)° γ=90.00°
C22H32N2O5
C22H32N2O5
Journal of the American Chemical Society (2019)
a=5.03210(10)Å b=18.5414(4)Å c=11.6101(2)Å
α=90° β=94.440(2)° γ=90°
Remacemide hydrochloride salt
C17H21N2O,Cl
Crystal Growth & Design (2005) 5, 2 427
a=10.660(2)Å b=8.712(2)Å c=17.624(3)Å
α=90.00° β=90.770(18)° γ=90.00°
C15H13BrN2O
C15H13BrN2O
Crystal Growth & Design (2013) 13, 11 5121
a=5.3472(2)Å b=10.3235(3)Å c=49.6238(17)Å
α=90.00° β=90.00° γ=90.00°
C8D10
C8D10
Journal of Molecular Structure (2000) 524, 121-128
a=10.1550Å b=7.4649Å c=16.8814Å
α=90.000° β=90.000° γ=90.000°
C8D10
C8D10
Journal of Molecular Structure (2000) 524, 121-128
a=5.7337Å b=4.9485Å c=11.1385Å
α=90.000° β=100.713° γ=90.000°